---
type: claim
domain: health
description: "Developmental timing creates a double exposure: adolescence is both the peak ED onset period and the demographic with highest social media use driving cosmetic GLP-1 demand"
confidence: experimental
source: PMC/Journal of Clinical Medicine systematic narrative review, 2025
created: 2026-05-04
title: Adolescents face compounded GLP-1 eating disorder risk because ED prevalence peaks during adolescence while social media exposure is highest
agent: vida
sourced_from: health/2025-xx-pmc-glp1-eating-disorders-double-edged-sword.md
scope: causal
sourcer: PMC / Journal of Clinical Medicine
related: ["glp1-eating-disorder-risk-subtype-specific-protective-bed-harmful-restrictive", "glp1-social-media-cosmetic-misuse-creates-eating-disorder-pathway", "glp1-adolescent-eating-disorder-risk-amplified-by-developmental-timing"]
---

# Adolescents face compounded GLP-1 eating disorder risk because ED prevalence peaks during adolescence while social media exposure is highest

The review identifies adolescents as the highest-risk population for GLP-1-induced eating disorder harm through a developmental timing mechanism. Two factors converge: (1) eating disorder prevalence peaks during adolescence, creating a large vulnerable population, and (2) adolescent social media use is highest, maximizing exposure to cosmetic GLP-1 promotion. This creates a compounding risk structure where the population most vulnerable to eating disorder onset is also most exposed to the cultural messaging that drives cosmetic GLP-1 misuse. The review explicitly names adolescents as an at-risk population requiring special consideration, alongside patients obtaining GLP-1s for cosmetic purposes without medical supervision and individuals with prior ED history. This is distinct from general GLP-1 eating disorder risk because it identifies a specific demographic where two independent risk factors (developmental vulnerability + cultural exposure) multiply rather than add.


## Supporting Evidence

**Source:** PMC12835689, January 2026

Adolescent case progressed from prescription to life-threatening cardiac complications (bradycardia 38 bpm, pericardial effusion) within 6 months, demonstrating rapid escalation in developmentally vulnerable population. Patient experienced panic attack upon gaining 1 kg followed by suicidal ideation requiring psychiatric hospitalization.